Dishman Pharmaceuticals and Chemicals Ltd(Merged)

Dishman Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dishman Pharmaceuticals and Chemicals Ltd(Merged)

₹ 301 2.71%
29 May 2017
dishmangroup.com BSE: 532526 NSE: DISHMAN
About

Dishman Pharmaceuticals and Chemicals Limited operates as an outsourcing partner for the pharmaceutical industry. The Company manufactures and supplies intermediates, fine chemicals and various products for pharmaceutical, cosmetic and related industries.

[ add key points ]
Website BSE NSE
  • Market Cap ₹ 4,861 Cr.
  • Current Price ₹ 301
  • High / Low ₹ /
  • Stock P/E 28.3
  • Book Value ₹ 104
  • Dividend Yield 0.00 %
  • ROCE 14.3 %
  • ROE 12.6 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 2.90 times its book value
  • The company has delivered a poor sales growth of 9.13% over past five years.
  • Company has a low return on equity of 10.9% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015 Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017
409 363 403 390 424 404 380 392 422 375 437 362 534
322 287 316 316 348 298 286 280 318 273 321 267 388
Operating Profit 88 75 88 74 76 106 94 112 105 102 116 95 146
OPM % 21% 21% 22% 19% 18% 26% 25% 29% 25% 27% 27% 26% 27%
17 4 1 8 73 4 8 -1 13 7 8 16 4
Interest 25 21 18 26 25 32 26 18 20 22 19 13 10
Depreciation 29 31 24 25 71 26 34 31 30 28 31 51 57
Profit before tax 50 29 47 31 53 52 42 62 67 58 74 46 83
Tax % 55% 17% 29% 21% 27% 23% 34% 27% 26% 22% 26% 37% 48%
23 24 33 24 39 40 28 44 50 46 55 29 43
EPS in Rs 2.80 2.95 4.13 2.98 4.78 4.96 3.44 5.55 6.19 2.82 3.39 1.79 2.65
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 TTM
277 578 803 1,062 915 1,031 1,124 1,272 1,385 1,589 1,596 1,708
213 468 659 801 712 830 899 982 1,053 1,275 1,186 1,249
Operating Profit 65 110 144 261 203 202 225 290 332 314 410 460
OPM % 23% 19% 18% 25% 22% 20% 20% 23% 24% 20% 26% 27%
12 31 60 8 29 14 13 18 25 86 27 34
Interest 10 19 34 49 39 56 73 79 92 90 94 65
Depreciation 12 26 47 63 59 69 77 84 109 151 109 168
Profit before tax 55 96 123 157 134 91 88 145 156 159 233 261
Tax % 6% 4% 2% 7% 13% 12% 35% 31% 30% 25% 27%
51 92 120 146 117 80 57 100 109 120 171 172
EPS in Rs 12.70 15.02 18.12 14.55 9.91 7.03 12.43 13.54 14.85 21.20 10.65
Dividend Payout % 9% 8% 7% 7% 8% 12% 17% 10% 9% 13% 9%
Compounded Sales Growth
10 Years: 19%
5 Years: 9%
3 Years: 8%
TTM: 7%
Compounded Profit Growth
10 Years: 13%
5 Years: 16%
3 Years: 20%
TTM: 6%
Stock Price CAGR
10 Years: 9%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: 13%
5 Years: 10%
3 Years: 11%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Equity Capital 14 14 16 16 16 16 16 16 16 16 16
Reserves 175 301 558 688 768 863 915 1,018 1,165 1,222 1,435
325 561 630 724 774 868 850 854 974 933 943
82 285 262 224 232 334 469 403 472 638 586
Total Liabilities 596 1,161 1,466 1,652 1,790 2,081 2,249 2,291 2,628 2,809 2,981
175 538 685 778 843 1,012 1,033 1,373 1,505 1,441 1,545
CWIP 37 65 148 223 357 307 418 97 79 142 85
Investments 7 14 1 1 1 1 26 25 25 25 25
376 544 631 650 588 761 771 796 1,019 1,201 1,325
Total Assets 596 1,161 1,466 1,652 1,790 2,081 2,249 2,291 2,628 2,809 2,981

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
15 43 49 132 302 203 154 165 344 294 279
-82 -418 -252 -168 -295 -231 -104 -117 -257 -158 -153
192 275 205 44 -7 25 -68 -50 -74 -142 -94
Net Cash Flow 126 -100 2 8 0 -3 -18 -2 14 -6 32

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Debtor Days 114 79 80 51 45 60 61 21 38 50 35
Inventory Days 306 537 375 339 316 272 253 328 414 298 524
Days Payable 134 118 74 55 104 172 157 102 82 101 94
Cash Conversion Cycle 286 498 381 335 258 160 157 247 369 247 465
Working Capital Days 208 151 157 138 137 98 92 103 118 109 140
ROCE % 16% 14% 16% 12% 9% 9% 12% 12% 12% 14%

Shareholding Pattern

Numbers in percentages

Jun 2016Sep 2016Dec 2016Mar 2017
61.40% 61.40% 61.40% 61.40%
19.30% 15.75% 15.08% 10.92%
4.64% 7.26% 7.87% 9.92%
14.66% 15.59% 15.65% 17.76%
No. of Shareholders 47,78143,89952,29152,417

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls